Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Tap

Showing results (211-220 of 235) with videos related to

Pageof 24
Sort By:
The Lancet. Oncology|March 13, 2013
Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: a multicentre, open-label, phase 2 trialGary K Schwartz, William D Tap, Li-Xuan Qin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 5, 2020
Clinical Cancer Advances 2020: Annual Report on Progress Against Cancer From the American Society of Clinical OncologyMerry Jennifer Markham, Kerri Wachter, Neeraj Agarwal, et al.
The Lancet. Oncology|June 28, 2017
Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trialWilliam D Tap, Zsuzsanna Papai, Brian A Van Tine, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Subclonal somatic copy number alterations emerge and dominate in recurrent osteosarcomaMichael D Kinnaman, Simone Zaccaria, Alvin Makohon-Moore, et al.
Cancer Research Communications|December 1, 2025
Tumor and Immune Dynamics Following Sequential CDK4/6 and PD-1 Inhibition: Results from a Phase 2 Study in Dedifferentiated LiposarcomaEvan Rosenbaum, Rodrigo Gularte-Mérida, Evan Seffar, et al.
Nature Communications|June 17, 2022
Pilot study of bempegaldesleukin in combination with nivolumab in patients with metastatic sarcomaSandra P D'Angelo, Allison L Richards, Anthony P Conley, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 11, 2016
Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in OncologyMargaret von Mehren, R Lor Randall, Robert S Benjamin, et al.
JCO Oncology Advances|May 7, 2025
ACR-368, a CHK1/2 Kinase Inhibitor, in Patients With Relapsed or Refractory Desmoplastic Small Round Cell Tumor: Phase I/II Trial ResultsEmily K Slotkin, Audrey Mauguen, Filemon S Dela Cruz, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 13, 2018
Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in OncologyMargaret von Mehren, R Lor Randall, Robert S Benjamin, et al.
Cancer Research|October 9, 2023
Subclonal Somatic Copy-Number Alterations Emerge and Dominate in Recurrent OsteosarcomaMichael D Kinnaman, Simone Zaccaria, Alvin Makohon-Moore, et al.
Pageof 24

Showing results (211-220 of 235) with videos related to

Sort By:
Pageof 24
The Lancet. Oncology|March 13, 2013
Cixutumumab and temsirolimus for patients with bone and soft-tissue sarcoma: a multicentre, open-label, phase 2 trialGary K Schwartz, William D Tap, Li-Xuan Qin, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 5, 2020
Clinical Cancer Advances 2020: Annual Report on Progress Against Cancer From the American Society of Clinical OncologyMerry Jennifer Markham, Kerri Wachter, Neeraj Agarwal, et al.
The Lancet. Oncology|June 28, 2017
Doxorubicin plus evofosfamide versus doxorubicin alone in locally advanced, unresectable or metastatic soft-tissue sarcoma (TH CR-406/SARC021): an international, multicentre, open-label, randomised phase 3 trialWilliam D Tap, Zsuzsanna Papai, Brian A Van Tine, et al.
Biorxiv : the Preprint Server for Biology|January 30, 2023
Subclonal somatic copy number alterations emerge and dominate in recurrent osteosarcomaMichael D Kinnaman, Simone Zaccaria, Alvin Makohon-Moore, et al.
Cancer Research Communications|December 1, 2025
Tumor and Immune Dynamics Following Sequential CDK4/6 and PD-1 Inhibition: Results from a Phase 2 Study in Dedifferentiated LiposarcomaEvan Rosenbaum, Rodrigo Gularte-Mérida, Evan Seffar, et al.
Nature Communications|June 17, 2022
Pilot study of bempegaldesleukin in combination with nivolumab in patients with metastatic sarcomaSandra P D'Angelo, Allison L Richards, Anthony P Conley, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 11, 2016
Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in OncologyMargaret von Mehren, R Lor Randall, Robert S Benjamin, et al.
JCO Oncology Advances|May 7, 2025
ACR-368, a CHK1/2 Kinase Inhibitor, in Patients With Relapsed or Refractory Desmoplastic Small Round Cell Tumor: Phase I/II Trial ResultsEmily K Slotkin, Audrey Mauguen, Filemon S Dela Cruz, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|May 13, 2018
Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in OncologyMargaret von Mehren, R Lor Randall, Robert S Benjamin, et al.
Cancer Research|October 9, 2023
Subclonal Somatic Copy-Number Alterations Emerge and Dominate in Recurrent OsteosarcomaMichael D Kinnaman, Simone Zaccaria, Alvin Makohon-Moore, et al.
Pageof 24